BPMC — Blueprint Medicines Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for Blueprint Medicines, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	872	477	945	711	615
Net Total Accounts Receivable
Net Total Receivables	25.3	37	36.9	43.2	77.6
Total Inventory
Prepaid Expenses
Total Current Assets	928	554	1,047	808	743
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	102	121	115	116	101
Long Term Investments
Other Long Term Assets
Total Assets	1,718	1,252	1,350	1,049	1,180
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	131	150	183	215	261
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	248	281	835	919	881
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,470	971	515	131	299
Total Liabilities & Shareholders' Equity	1,718	1,252	1,350	1,049	1,180
Total Common Shares Outstanding